Address: Beybi Giz Kule, Meydan Sok. No:1 Kat:22 34398 Maslak ,Turkey
Tel: (90-212) 329 14 00
Web: http://www.servier.com.tr/
• Leading French independent pharmaceutical company
• Second French pharmaceutical company worldwide
• Present in 140 countries over 5 continents
• 90% of Servier’s medicines are consumed internationally
• 2010/2011 turnover of 3.9 billion euros
• 25% of turnover invested in R&D
• Worldwide workforce of over 20 000, including nearly 3000 researchers preparing the drugs of the future
• Servier contributes 29% of the trade surplus of France’s pharmaceutical industry
We are driven by the belief in the excellence of our profession.
Ours is a research-based organization, fulfilling a basic need and dedicated to the future.
Gilles Renacco, the recently appointed general manager of Servier Turkey, provides insights into the successful localization process pioneered by Servier in the country, where 98 percent of the company’s products…
Turkey is a key market in the region for Servier, says general manager Philippe Méa, largely due to the country’s relatively strong and stable vision for the healthcare industry. The…
Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the generic penetration is much lower…
With its current turbulent economic and political climate, Turkey is betting its future prosperity on 2 key aspects – its young talent pool and its location as an intersection between…
Ersin Erfa, general manager of Centurion, which recently set up one of Turkey’s largest biotechnology plants in Ankara, dives into the world of double-digit growth and a booming export business,…
Prof. Dr. Sabahattin Aydın, Rector of Medipol University, chairman of the Executive Council of TUSAP Healthcare Platform, former executive board member of the World Health Organization (WHO), former deputy undersecretary…
Fikret Baltaoglu of Laboratoires Expanscience, reveals all on the company’s recent expansion into the Turkish market after acquiring its distribution partner. He also sheds light on how the Turkish healthcare…
Hasan Ulusoy, chairman of Nobel Ilac, elaborates on his company’s tremendous successes in Turkey and how they have differentiated themselves through early investment in biotechnology and firmly grasping international opportunities.…
Hakan Yurdakul, Head of Economy Monitoring and Coordination at the Presidency Office of the Republic of Turkey, elaborates on the strategic importance of the pharmaceutical and healthcare industries for the…
Prof. Dr. Temel Yilmaz, president of the Turkish Diabetes Foundation, discussed how the disease has made a massive impact in country and what can be done to tackle the issue…
Two months into the role, Umut Meriç, general manager for Chiesi Turkey, discusses the affiliate’s rapid progression and his plans to ensure Turkish patients benefit from the global company’s latest…
From collaborating with authorities to tackling awareness surrounding mental illnesses, Altan Gorseval, country manager of Lundbeck Turkey, paints an accurate picture of the company’s dedication to improving mental health and…
Turkey has one of the most revered Social Security Systems in the world, providing its citizens with free healthcare and access to a long list of innovative cancer drugs. However, with one…
Dr. Hakkı Gürsöz, president of the Turkish Medicines and Medical Devices Agency (TiTCK), provides insights into recent localization and pricing policies and delivers strong messages to both domestic and foreign…
Dr. Erdal Bozdoğan, the recently appointed general manager of Takeda Turkey, leverages his 20 years of experience in the pharmaceutical industry and his expertise of emerging markets to document Turkey’s…
See our Cookie Privacy Policy Here
